跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 134 条关于
“Phiogen”
全部
134
临床试验
8
药物
41
机构
22
资讯
63
去年
CARB-X Awards $1.1 Million to Phiogen for Novel Bacteriophage Treatment Against Drug-Resistant E. coli Bloodstream Infections
上个月
Philogen Resubmits Nidlegy Marketing Application to EMA with Extended Phase III Melanoma Data
去年
Biogen Withdraws Aduhelm EU Application Following Regulatory Setback
去年
Sun Pharma and Philogen Complete Enrollment for Pivotal Phase III FIBROSARC Trial in Soft Tissue Sarcoma
去年
Eisai and Biogen Pursue Subcutaneous Leqembi Approval for Alzheimer's
2年前
Biogen Expands into Immunology with Acquisition of HI-Bio
去年
Biogen Advances LEQEMBI Treatment with Subcutaneous Formulation for Alzheimer's Disease
去年
Eisai and Biogen Launch Alzheimer's Drug Leqembi in South Korea
去年
Biogen Executives Address Investor Pressure and Strategic Focus at JPM25
去年
Biogen's Felzartamab Receives FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
第 1 页,共 7 页
上一页
下一页